FLR (NYSE) Form 144 lists 166,900-share resale via Merrill Lynch

Rhea-AI Filing Summary

FLR reported a proposed resale of Common Stock via a Form 144 filing. The filing lists a broker-dealer Merrill Lynch and shows 166,900 shares alongside numbers 9,004,400 and 139,669,896 with an as of date of 06/11/2026. The filing itemizes restricted-stock awards dated 03/06/2023 (50,608), 12/23/2023 (18,323), and 03/06/2024 (97,969).

Insights

Corporate Securities Counsel

Routine Form 144 notice listing broker, proposed shares, and award details.

The excerpt lists 166,900 shares in proximity to broker information and includes two larger numeric fields (9,004,400 and 139,669,896) with an 06/11/2026 date. These appear as filing line items; the excerpt does not attach explicit labels explaining each number.

Timing and cash-flow treatment are not described in the excerpt; subsequent SEC filings or broker disclosures would state whether these sales occur under Rule 144 or other resale mechanics.

Key Figures

Proposed resale shares: 166,900 shares Numeric line item: 9,004,400 Numeric line item: 139,669,896 +3 more

6 metrics

Proposed resale shares 166,900 shares listed adjacent to Merrill Lynch with date <date>06/11/2026</date>

Numeric line item 9,004,400 appears in the same row group with date <date>06/11/2026</date>

Numeric line item 139,669,896 appears in the same row group with date <date>06/11/2026</date>

Restricted award (03/06/2023) 50,608 shares grant dated <date>03/06/2023</date>

Restricted award (12/23/2023) 18,323 shares grant dated <date>12/23/2023</date>

Restricted award (03/06/2024) 97,969 shares grant dated <date>03/06/2024</date>

Key Terms

Form 144, Restricted stock, Broker-dealer

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted stock financial

"RESTRICTED STOCK | FLUOR CORPORATION | 50608"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Broker-dealer regulatory

"Merrill Lynch 13355 Noel Road Suite Suite 700 Dallas TX"

A broker-dealer is a licensed firm or individual that both executes trades on behalf of clients (acting as a broker) and buys or sells securities for its own account (acting as a dealer). Investors care because broker-dealers provide the plumbing of markets — they place orders, hold or move cash and securities, offer research or advice, and their stability and fees directly affect trade execution, costs, and the safety of client funds; think of them as a combined travel agent and taxi for your investments.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 13355 Noel Road Suite Suite 700 Dallas TX 75240	166900	9004400	139669896	06/11/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	03/06/2023	RESTRICTED STOCK	FLUOR CORPORATION			50608	03/06/2023	EQUITY AWARD
COMMON	12/23/2023	RESTRICTED STOCK	FLUOR CORPORATION			18323	12/23/2023	EQUITY AWARD
COMMON	03/06/2024	RESTRICTED STOCK	FLUOR CORPORATION			97969	03/06/2024	EQUITY AWARD

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does FLR's Form 144 show about proposed sales?

The Form 144 lists a proposed resale entry showing 166,900 shares associated with Merrill Lynch and a filing date of 06/11/2026. The excerpt presents these figures as line items without describing the specific sale method or proceeds.

Which restricted-stock awards are listed in the FLR excerpt?

The excerpt itemizes restricted-stock awards dated 03/06/2023 (50,608 shares), 12/23/2023 (18,323 shares), and 03/06/2024 (97,969 shares). Each award row is shown with its grant date and share count.

Who is the broker-dealer named in the filing and what role is shown?

The broker-dealer is listed as Merrill Lynch, 13355 Noel Road, Dallas, TX. The excerpt places that broker name adjacent to the 166,900 share line, indicating the broker-dealer for the proposed resale transaction.

Do the numbers 9,004,400 and 139,669,896 indicate outstanding shares?

The excerpt shows the figures 9,004,400 and 139,669,896 alongside the 06/11/2026, but it does not explicitly label them. The text presents them as line entries; the filing fragment does not attach a clear descriptive label.

Does the Form 144 excerpt state who receives proceeds from any sale?

The provided excerpt does not state the recipient of sale proceeds. It lists broker and share-line items but does not include language describing cash-flow treatment or whether proceeds go to the issuer or selling holder.